PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
+21.51%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$303M
AUM Growth
+$303M
(+25%)
Cap. Flow
+$12.6M
Cap. Flow
% of AUM
4.15%
Top 10 Holdings %
Top 10 Hldgs %
99.76%
Holding
11
New
–
Increased
3
Reduced
1
Closed
–
Top Buys
| 1 |
Arcutis Biotherapeutics
ARQT
|
$5.11M |
| 2 |
Vaxcyte
PCVX
|
$4.99M |
| 3 |
INZY
Inozyme Pharma
INZY
|
$2.49M |
Top Sells
| 1 |
EXAI
Exscientia Plc American Depositary Shares
EXAI
|
$10.6K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $170M | 55.9% | 782,008 | – | – |
|
|
2
Vaxcyte
PCVX
$4B
| $39.6M | 13.06% | 793,036 +99,997 | +14% | +$4.99M |
|
3
Oculis Holding
OCS
$844M
| $29.4M | 9.68% | 2,381,196 | – | – |
|
|
INZY
4
DELISTED
Inozyme Pharma
INZY
| $20.4M | 6.72% | 3,661,518 +447,932 | +14% | +$2.49M |
|
5
Rallybio
RLYB
$22.4M
| $13.6M | 4.49% | 2,404,644 | – | – |
|
|
6
Arcutis Biotherapeutics
ARQT
$1.86B
| $10.5M | 3.47% | 1,105,309 +536,268 | +94% | +$5.11M |
|
|
FUSN
7
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $7.29M | 2.4% | 1,560,982 | – | – |
|
|
VIGL
8
DELISTED
Vigil Neuroscience
VIGL
| $5.27M | 1.74% | 560,595 | – | – |
|
|
EXAI
9
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $4.56M | 1.5% | 770,500 -1,785 | -0.2% | -$10.6K |
|
10
Bolt Biotherapeutics
BOLT
$9.85M
| $2.42M | 0.8% | 1,891,467 | – | – |
|
11
Aligos Therapeutics
ALGS
$73.3M
| $722K | 0.24% | 743,215 | – | – |
|